UPDATE : Friday, November 16, 2018
상단여백
Hanmi rolls out new generic drug to beat Pfizer’s anti-nicotine therapy
After failing to outrival Pfizer in the anti-smoking treatment market with ...
by So Jae-hyeon  |  2018-11-07 16:07
라인
‘Korea fighting losing battle against antimicrobial resistance’
The threat of antimicrobial resistance (AMR) is spreading rapidly, and Kore...
by Lee Han-soo  |  2018-11-07 16:07
라인
Ministry OKs P1 clinical trials for JW’s atopy treatment
JW Pharmaceutical said Wednesday that it has received approval from the Min...
by Lee Han-soo  |  2018-11-07 16:06
라인
Two Koreas discuss jointly blocking infectious diseases
Health authorities from South and North Korea met on Wednesday, 11 years af...
by Kwak Sung-sun  |  2018-11-07 15:00
라인
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon  |  2018-11-07 14:58
라인
Huons completes P3 clinical trials for Hutox
Huons Global said Tuesday that it has completed domestic phase 3 clinical t...
by Lee Han-soo  |  2018-11-07 12:26
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun  |  2018-11-07 11:23
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon  |  2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun  |  2018-11-06 15:41
라인
Sanofi confirms continuous therapeutic benefits for relapsing-remitting multiple sclerosis treatment
Sanofi Genzyme Korea said Tuesday that it has presented a new study on Lemt...
by Lee Han-soo  |  2018-11-06 11:09
라인
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon  |  2018-11-06 11:06
라인
Samsung BioLogics to complete Biogen’s call option
Samsung BioLogics posted Tuesday that the transfer of assets related to Sam...
by Lee Han-soo  |  2018-11-06 10:45
라인
SMC completes 20 cases of artificial heart transplant
Samsung Medical Center said Monday that it has become the first local hospi...
by Lee Han-soo  |  2018-11-06 10:44
라인
Will PharmAbcine be new force on KOSDAQ?
PharmAbcine, an immuno-oncology company, might be a promising biotech firm ...
by Nam Doo-hyun  |  2018-11-05 16:32
라인
GTG Wellness to export body composition analyzer to Australia
GTG Wellness CEO Kim Tae-hyun (left) and Evolt IOH CEO Ed Zouroudis hold up...
by Lee Han-soo  |  2018-11-05 16:32
라인
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon  |  2018-11-05 15:26
라인
Does Korean traditional cold remedy work?
With the temperature dropping down, the number of Koreans coming down with ...
by Lee Han-soo  |  2018-11-05 15:25
라인
Korea to promote digital healthcare firms in Southeast Asia
The Ministry of Health and Welfare will hold an event in Hanoi and Jakarta ...
by Kwak Sung-sun  |  2018-11-05 14:29
라인
GC starts developing shingles vaccine in US
GC said Monday that its U.S. subsidiary Cuervo has received U.S. Food and D...
by Lee Han-soo  |  2018-11-05 13:31
라인
‘Different medical training may impede inter-Korean healthcare cooperation’
The different medical training system for physicians and nurses between two...
by Kwak Sung-sun  |  2018-11-05 13:30
여백
여백
여백
Back to Top